3000 Participants Needed

Novel Healthcare Approaches for Delirium in Elders

(ENHANCE Trial)

Recruiting at 7 trial locations
ES
Overseen ByEva Schmitt, PhD
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: University of Michigan
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment FAM-HELP for delirium in elders?

The Hospital Elder Life Program (HELP), which FAM-HELP is based on, has been shown to effectively prevent delirium in older hospitalized adults, leading to lower rates of delirium, shorter hospital stays, and greater satisfaction among patients and families.12345

Is the Hospital Elder Life Program (HELP) safe for older adults?

The Hospital Elder Life Program (HELP) is generally considered safe for older adults, as it has been successfully implemented in various settings to prevent delirium without reported safety concerns. It is well-received by patients, families, and healthcare staff, and has been shown to improve patient satisfaction and reduce hospital costs.12467

How is the FAM-HELP treatment different from other treatments for delirium in elders?

FAM-HELP is unique because it combines the Hospital Elder Life Program (HELP) with family support to prevent delirium in older adults. This approach is novel as it involves family members in the care process, enhancing the traditional HELP model, which focuses on non-drug interventions like orientation, cognitive activities, and sleep promotion.12489

What is the purpose of this trial?

The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are the following:1. To compare the effectiveness of FAM-HELP and HELP in reducing both the incidence of delirium and its severity.2. To compare the effectiveness of FAM-HELP and HELP in improving patient- and family-reported outcomes.3. To explore the implementation context, process, and outcomes of the FAM-HELP program in diverse hospital settings.

Research Team

PE

Phillip E Vlisides, MD

Principal Investigator

University of Michigan

SK

Sharon K Inouye, MD

Principal Investigator

Hebrew SeniorLife

Eligibility Criteria

This trial is for people aged 70 or older who are hospitalized and expected to stay at least 72 hours. They must have a family member available to help, be able to give consent, and have at least one risk factor for delirium but not already be delirious upon admission.

Inclusion Criteria

I am 70 years old or older.
Family member or care partner available to be on-site in the hospital
Provision of informed consent
See 2 more

Exclusion Criteria

I cannot speak due to my current health condition.
I am not able to fully participate in treatments due to a severe condition.
Staff safety concerns (e.g., violent behavior)
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive either the HELP or FAM-HELP program to prevent delirium during hospitalization

Up to 14 days
Daily in-hospital visits

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments of cognitive function and delirium burden

30 days
1-2 follow-up visits (in-person or virtual)

Long-term Follow-up

Participants are monitored for hospital readmission and persistent delirium

30 days after discharge

Treatment Details

Interventions

  • FAM-HELP
  • HELP
Trial Overview The study compares two programs: HELP, which supports elderly patients in hospitals, and FAM-HELP, which includes family in the care process. It aims to see if involving families can better prevent or reduce the severity of delirium.
Participant Groups
2Treatment groups
Active Control
Group I: Hospital Elder Life Program (HELP)Active Control1 Intervention
Hospital Elder Life Program (HELP) is built upon multicomponent, non-pharmacologic strategies that target delirium risk factors to optimize cognitive and clinical function during hospitalization.
Group II: Family-Augmented Hospital Elder Life Program (FAM-HELP)Active Control1 Intervention
The FAM-HELP program will incorporate a family member and/or care partner, who will play a central role with providing bedside support for delirium risk reduction. Family members and care partners will provide social and emotional support along with augmentation of HELP-based protocols.

FAM-HELP is already approved in United States, Canada for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as FAM-HELP for:
  • Prevention of delirium in older hospitalized adults
๐Ÿ‡จ๐Ÿ‡ฆ
Approved in Canada as FAM-HELP for:
  • Prevention of delirium in older hospitalized adults

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

University of Utah

Collaborator

Trials
1,169
Recruited
1,623,000+

Indiana University

Collaborator

Trials
1,063
Recruited
1,182,000+

UnityPoint Health - Meriter Hospital

Collaborator

Trials
1
Recruited
3,000+

West Penn Allegheny Health System

Collaborator

Trials
36
Recruited
6,000+

MemorialCare Saddleback Medical Center

Collaborator

Trials
1
Recruited
3,000+

University of Pennsylvania

Collaborator

Trials
2,118
Recruited
45,270,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

Hebrew SeniorLife

Collaborator

Trials
52
Recruited
273,000+

MaineHealth

Collaborator

Trials
76
Recruited
43,800+

Findings from Research

The Hospital Elder Life Program (HELP) has been successfully implemented and sustained over 7 years in a community teaching hospital, expanding from one to six inpatient units and serving over 7,000 older patients annually, establishing it as the standard of care.
The program has led to significant improvements, including a lower rate of delirium, shorter hospital stays, increased satisfaction among patients and staff, and substantial cost savings of over $7.3 million per year, highlighting its effectiveness in enhancing care for older adults.
Sustainability and scalability of the hospital elder life program at a community hospital.Rubin, FH., Neal, K., Fenlon, K., et al.[2022]
The Modified and Extended Hospital Elder Life Program (HELP-ME) was successfully implemented at four sites with 106 patients, achieving an overall protocol adherence rate of 82%, which meets the feasibility target of over 75%.
Feedback from focus groups indicated that while the remote intervention was generally well-accepted, a hybrid approach combining in-person and remote strategies may enhance effectiveness and sustainability in preventing delirium.
The Modified and Extended Hospital Elder Life Program: A remote model of care to expand delirium prevention.Fong, TG., Albaum, JA., Anderson, ML., et al.[2023]
The Hospital Elder Life Program (HELP) significantly reduced the prevalence of delirium in older patients from 10.9% to 2.5% in a rehabilitation setting, while the usual care group showed no change.
Patients receiving HELP demonstrated greater improvements in cognitive and functional outcomes, including short-term memory and recall, and had a shorter average length of stay compared to those who did not receive the intervention.
Examining the Hospital Elder Life Program in a rehabilitation setting: a pilot feasibility study.Huson, K., Stolee, P., Pearce, N., et al.[2019]

References

Sustainability and scalability of the hospital elder life program at a community hospital. [2022]
The Modified and Extended Hospital Elder Life Program: A remote model of care to expand delirium prevention. [2023]
Examining the Hospital Elder Life Program in a rehabilitation setting: a pilot feasibility study. [2019]
Hospital Elder Life Program in the real world: the many uses of the Hospital Elder Life Program website. [2021]
The Modified Hospital Elder Life Program (HELP) in geriatric hospitalized patients in internal wards: A double-blind randomized control trial. [2021]
Hospital Elder Life Program in Long-Term Care (HELP-LTC): A Cluster Randomized Controlled Trial. [2023]
A volunteer-based Hospital Elder Life Program to reduce delirium. [2019]
[HELP - Hospital Elder Life Program - multimodal delirium prevention in elderly patients]. [2019]
A Multi-Phase Quality Improvement Initiative for the Treatment of Active Delirium in Older Persons. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity